The Health Policy Partnership and Professor Ken Herrmann have published a poster at the virtual European Society for Medical Oncology (ESMO) congress, which ran from 14 September to 18 October 2020.
The poster focuses on the development of the first radioligand therapy readiness assessment framework. It explores the need for health system readiness for radioligand therapy and the method adopted to develop the framework. It highlights how the framework can be used to support evidence-based policy and planning for the integration of radioligand therapy into cancer care.
The poster has been made available online in Annals of Oncology, the ESMO journal.